SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Aardvark Adventures
DAVE 207.00-1.5%Dec 5 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: ~digs10/17/2006 5:20:20 AM
   of 7944
 
CAMH.ob 2.5

Cambridge Heart, Inc. engages in the research, development, and commercialization of products for the noninvasive diagnosis of cardiac diseases in the United States and internationally. Its products primarily include the Heartwave II System used to perform a Microvolt T-Wave Alternans Test that requires an elevated heart rate to provide an accurate result; the CH 2000 Cardiac Stress Test System, a diagnostic system that supports a range of standard and physician-customized protocols for the conduct and measurement of cardiac exercise stress tests; and the Micro-V Alternans Sensors, which are single patient use, multisegment electrodes that are required for the Microvolt T-Wave Alternans Test.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext